Category
Baricitinib
CAS Number
1146629-76-6
Molecular Formula
C₁₉H₂₅N₅O₃
Molecular Weight
371.43 g/mol
Synonym

[4-[1-(1-Ethoxyethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl 2,2-dimethylpropanoate ; [4-[1-(1-Ethoxyethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate; Baricitinib Impurity 6 (Stage-2)

Keywords
Pharmaceutical Intermediates
Heterocycles
Impurities
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

The compound (4-(1-(1-Ethoxyethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate is a chemical intermediate or derivative related to Baricitinib. It contains a pyrazole and pyrrolopyrimidine core, functionalized with an ethoxyethyl group and a pivalate ester, which can be involved in the synthesis pathway or impurity profile of Baricitinib. This type of compound is usually monitored during drug development to ensure purity and control of potential impurities.